Apr 2, 2026 08:33AM

Apr 2, 2026 08:30AM

Mar 10, 2026 08:32AM

Mar 10, 2026 08:30AM

Mar 5, 2026 09:00AM

Jan 20, 2026 08:05AM

Jan 20, 2026 08:05AM Dermata Receives Notice of Grant of Patent for Next-Generation Acne Treatment by Australian Patent Office

Dec 29, 2025 04:05PM

Dec 29, 2025 04:05PM

Dec 24, 2025 08:00AM

Dec 24, 2025 08:00AM

Dec 4, 2025 08:00AM

Oct 2, 2025 08:02AM

Oct 2, 2025 08:00AM Dermata Announces Acceptance of Patent Application for Next-Generation Acne Treatment by Australian Patent Office

Sep 17, 2025 01:00AM

Sep 10, 2025 08:01AM

Sep 10, 2025 08:00AM

Jul 8, 2025 08:01AM

Jul 8, 2025 08:00AM

May 14, 2025 09:00AM

Apr 15, 2025 08:35AM Dermata's (DRMA) XYNGARI Phase 3 trial shows significant difference

Apr 15, 2025 08:30AM

Mar 27, 2025 08:15PM

Mar 27, 2025 08:01AM

Mar 17, 2025 04:16PM

Feb 25, 2025 07:59AM

Feb 25, 2025 07:58AM

Jan 29, 2025 04:05PM Dermata to Present on BioPub on January 31, 2025

Jan 23, 2025 04:15PM

Jan 22, 2025 08:04AM

Jan 22, 2025 08:00AM

Jan 21, 2025 08:03AM

Jan 21, 2025 08:00AM

Dec 16, 2024 09:00AM

Dec 10, 2024 09:08AM Dermata Therapeutics, Inc (DRMA) Receives Notice of Allowance for New U.S. Patent for DMT310 for the Treatment of Acne

Dec 10, 2024 09:00AM

Dec 3, 2024 09:00AM

Oct 8, 2024 04:15PM

Sep 17, 2024 05:15PM

Sep 16, 2024 09:00PM

Jul 17, 2024 09:00AM

401,453 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All